MAPT and Alzheimer disease: In addition, Calderon-Garciduenas et al. recently reported elevated levels of non-phosphorylated tau in the CSF, a marker of AD axonal pathology, or increases in hyperphosphorylated tau and amyloid plaques in the OB of children and young adults in Mexico City [51,59].